This Big Player in the COVID-19 Market Just Lowered Its Forecast. Should You Be Worried?

Coronavirus-vaccine makers have drawn most of the attention since the start of the pandemic and they've recently started earning revenue from their products. But there are companies that served the coronavirus market much earlier -- and have made billions over the past year. I'm talking about makers of coronavirus tests.

My favorite is Abbott Laboratories (NYSE: ABT). The company has generated more than $6 billion since the start of the pandemic from its COVID-19 diagnostics. But Abbott disappointed investors this week when it lowered its annual forecast.

Now the question is: Should you be worried -- or even avoid shares of this testing giant? Let's take a closer look.

Continue reading

Source Fool.com